#biotech - Signalsrobot News

#biotech

News Stocks

Sonnet BioTherapeutics (NASDAQ:SONN) Trading Down 67.3% – Here’s What Happened

SignalsRobot

0 26 0

News Stocks

Best Biotech Stocks To Follow Now – December 28th

SignalsRobot

0 43 0

News Stocks

Swedbank AB Has $76.83 Million Position in Neurocrine Biosciences, Inc. $NBIX

SignalsRobot

0 99 0

News Stocks

Genenta Science Provides Update on CEO Ownership

SignalsRobot

0 42 0

News Stocks

Syneron Bio Closes Nearly $100M in Series A and A+ Rounds

SignalsRobot

0 50 0

News Stocks

UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington’s Data Spurs Mizuho Downgrade and Delayed Launch

SignalsRobot

0 31 0

News Stocks

Top Biotech Stocks Worth Watching – December 13th

SignalsRobot

0 85 0

News Stocks

Jasper Stock Jumps After Promising New Asthma Study Results

SignalsRobot

0 83 0

News Stocks

Earns Buy Rating at Truist as HIV Franchise Continues to Deliver

SignalsRobot

0 49 0

News Stocks

Head to Head Comparison: TuHURA Biosciences (HURA) versus Its Peers

SignalsRobot

0 59 0

News Stocks

AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?

SignalsRobot

0 79 0

News Stocks

Crypto Company Creates Bizarre Drug

SignalsRobot

0 47 0

News Stocks

Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain

SignalsRobot

0 73 0

News Stocks

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

SignalsRobot

0 111 0

News Stocks

Dallas’ Curve Biosciences Raises $40M for Its ‘Whole-Body Intelligence’ Disease Monitoring Platform

SignalsRobot

0 52 0

News Stocks

Top Biotech Stocks To Follow Now – November 5th

SignalsRobot

0 88 0

News Stocks

Intech - Hanbon Launches Advanced Peptide Synthesizer Machine For High-Precision Laboratory Applications

SignalsRobot

0 102 0

News Stocks

Biogen (NASDAQ:BIIB) Price Target Raised to $150.00

SignalsRobot

0 60 0

News Stocks

Top Biotech Stocks To Keep An Eye On – October 28th

SignalsRobot

0 66 0

News Stocks

Novartis Agrees to Buy Avidity Biosciences for $72 Per Share

SignalsRobot

0 120 0